We serve Chemical Name:7-Bromoisoquinoline hydrochloride (1:1) CAS:223671-91-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:7-Bromoisoquinoline hydrochloride (1:1)
CAS.NO:223671-91-8
Synonyms:Isoquinoline, 7-bromo-, hydrochloride (1:1);7-Bromoisoquinoline hydrochloride (1:1);7-bromoisoquinoline HCl;7-bromoisoquinoline hydrochloride
Molecular Formula:C9H7BrClN
Molecular Weight:244.516
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.89000
Exact Mass:242.945038
LogP:3.79930
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Isoquinoline, 7-bromo-, hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-bromoisoquinoline hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-bromoisoquinoline hydrochloride Use and application,7-Bromoisoquinoline hydrochloride (1:1) technical grade,usp/ep/jp grade.
Related News: With the continuous advancement of economic globalization, the division of labor and cooperation around the world has become increasingly apparent. The fine chemical industry has the foundation of global division of labor and cooperation due to its long and complex industrial chain. 7-Bromoisoquinoline hydrochloride (1:1) manufacturer Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 7-Bromoisoquinoline hydrochloride (1:1) supplier Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). 7-Bromoisoquinoline hydrochloride (1:1) vendor He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 7-Bromoisoquinoline hydrochloride (1:1) factory Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs).
